View of statins as antimicrobials in cardiovascular risk modification

Area of Science:

• Cardiovascular Medicine
• Pharmacology
• Microbiology

Background:

• Atherosclerosis, a major cause of heart attack and stroke, involves dyslipidemia and inflammation, leading to obstructive arterial plaques.
• Cardiovascular disease (CVD) management often involves statins, a highly effective drug class.
• Emerging research suggests statins may have antimicrobial effects beyond their lipid-lowering actions.

Purpose of the Study:

• To review the potential antimicrobial activity of statins.
• To explore the extension of statin applications to inflammatory conditions beyond cardiovascular disease.

Main Methods:

• Literature review of studies investigating statins and their effects.
• Analysis of pleiotropic effects of statins, focusing on antimicrobial properties.
• Assessment of evidence for antibacterial activity in various inflammatory contexts.

Main Results:

• Statins exhibit pleiotropic effects beyond cholesterol reduction.
• Evidence suggests potential antimicrobial and antibacterial activities of statins.
• These activities may be relevant for treating inflammatory conditions.

Conclusions:

• Statins may possess significant antimicrobial properties.
• Their antibacterial effects could broaden therapeutic applications for vascular and other inflammatory diseases.
• Further research is warranted to fully elucidate and utilize these antimicrobial effects.